CEO Professor Alan Trounson AO said, “Bringing new cutting-edge technologies such as CLIP-CAR together with Cartherics’ allogeneic NK cell platform is an exciting development that may make these therapies even more effective."
Cartherics enters new collaborative research agreement with TiCARos
April 3, 2024 Australian Biotech
Latest Video
New Stories
-
UK life sciences report highlights pressures familiar to Australian industry
January 27, 2026 - - Latest News -
Americans pay a much lower share of health costs than we do in Australia
January 27, 2026 - - Latest News -
Australia’s health information ecosystem is very full, but do the best voices dominate?
January 27, 2026 - - Latest News -
Strong US debut for Novo Nordisk pill signals potential shift in global weight loss market
January 26, 2026 - - Latest News -
Leading pharmacists honoured in 2026 Australia Day Awards
January 26, 2026 - - Latest News -
This regulatory restriction is too harmful to be described as simply outdated
January 25, 2026 - - Latest News -
The 'Dispatched' Podcast - Episode 1, Series 5
January 23, 2026 - - Podcast

